Office of Research Proposal Development
The Office of Research Proposal Development assists faculty in developing proposals for federal funding. The services offered by the Office of Research Proposal Development are broad, including: convening meetings of researchers for multi-investigator funding opportunities; working with investigators and sponsors to understand proposal requirements; developing a proposal preparation schedule with critical milestones and internal deadlines; creating proposal templates; gathering and formatting commonly required elements materials (biographical sketches, facilities statements, data management plan, etc.); vetting and editing all sections of the proposal.
NIH Grants
- Notice of Fiscal Policies in Effect for FY 2024
- Notice of Special Interest (NOSI): Promoting Data Reuse for Health Research
- Notice of Cancellation of the June 18, 2024 Application Receipt Date for RFA-EY-23-001 "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)"
- Notice of Change to NHGRI-specific language in RFA-HG-23-018, Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
- Notice of Special Interest (NOSI): Exploring the Effects of Endocannabinoids and Exogenous Cannabinoids on Brain Development
- Notice of Legislative Mandates in Effect for FY 2024
- Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed)
- Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
- Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional)
- Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)
- Notice of Special Interest (NOSI) on Catalyzing Research and Training on the Impact of HIV on the Health Across the Lifespan of Women Living with HIV Through Administrative Supplements to Existing Fogarty International Centers HIV Programs
- NINDS Policy for applications requesting $500,000 or more in direct costs in any year (excluding consortium F and A)on NIH Parent R01 Notices of Funding Opportunities
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
- Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
- NIDCD Individual Fellowship Pre-Application Information Session
- Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research
- Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)